(Stroke. 1995;26:2307-2312.)
© 1995 American Heart Association, Inc.
Articles |
From the National Naval Medical Center, Naval Medical Research Institute, Bethesda, Md (R.B.M., A.J.D.); and the Department of Critical Care, Children's National Medical Center, Washington, DC (R.B.M.).
Correspondence to Richard B. Mink, MD, Division of Critical Care, Cardinal Glennon Children's Hospital, 1465 S Grand Blvd, St Louis, MO 63104. E-mail Richard-M@wpogate.slu.edu.
| Abstract |
|---|
|
|
|---|
Methods Rabbits were subjected to 10 minutes of global cerebral ischemia by cerebrospinal fluid compression. After 30 minutes of reperfusion, rabbits either were subjected to HBO for 125 minutes and then breathed 100% O2 at ambient pressure for 90 minutes or breathed 100% O2 for 215 minutes. At the end of reperfusion and 90 minutes after exposure, brain vascular permeability and cerebral blood flow were measured. Somatosensory evoked potentials were monitored throughout the experiment.
Results HBO treatment reduced (P<.05) brain vascular permeability by 16% in gray matter and by 20% in white matter. Cerebral blood flow was lower (P<.05) in the HBO group (40.9±1.9 mL/min per 100 g, mean±SEM) compared with controls (50.8±2.0 mL/min per 100 g). Somatosensory evoked potential recovery was similar in the two groups (P>.05).
Conclusions HBO administered after global cerebral ischemia promoted blood-brain barrier integrity. HBO treatment also reduced cerebral blood flow; this effect was not associated with a reduction in evoked potential recovery. Since neurological outcome after global cerebral ischemia is generally poor and treatment options are limited, HBO should be further investigated as a potential therapy.
Key Words: blood-brain barrier cerebral blood flow hyperbaric oxygenation somatosensory evoked potentials rabbits
| Introduction |
|---|
|
|
|---|
The ability of HBO to improve neurological recovery after cerebral injury is controversial, as studies in both animals and humans have yielded conflicting results.2 6 7 8 Some of the discrepancy in the results of these studies is due to the fact that the investigations vary widely in the time after insult at which HBO was administered, many depths and durations of exposure have been used, and most studies have not had adequate controls. In addition, although there has been interest in the use of HBO after traumatic brain injury or stroke,6 9 only a few investigations have examined the effect of HBO on brain damage after global ischemia. Because there are differences in the pathophysiology of focal and global ischemia,10 the efficacy of HBO may also be influenced by the specific insult. A recent investigation in our laboratory suggested that HBO may improve brain recovery after global ischemia when given immediately after the insult.11
The purpose of this study was to examine the effect of HBO administered after global ischemia on early brain injury. We used a rabbit model of global cerebral ischemia and a compression protocol designed to be clinically relevant and clinically feasible. Brain injury was evaluated with somatosensory evoked potential (SEP) recovery and with measurements of cerebral blood flow (CBF) and vascular permeability. We hypothesized that HBO would improve evoked potential recovery and reduce brain edema but not alter CBF.
| Materials and Methods |
|---|
|
|
|---|
-chloralose (50 mg/kg IV) and urethane (100
mg/kg IV as needed). An endotracheal tube was placed through a
tracheostomy, and the rabbits were mechanically ventilated for the
duration of the experiment. Bilateral femoral arterial and
venous lines were inserted by surgical cutdown. These lines were used
to monitor blood pressure, sample blood for measurement of
arterial pH, PCO2,
PO2, and hematocrit, and administer
fluids and drugs. Body temperature was monitored with a rectal probe
and maintained at 39.5±0.5°C. After the animal was positioned in a
stereotaxic frame, electrodes were placed to measure SEPs
(NIC CA 1000, Nicolet Biomedical Instruments) over the right cerebral
cortex with stimulation of the left median nerve (stimulus 10 to 17 mA,
duration 100 microseconds, 1.7 repetitions per second, band-pass
filters 30 to 3000 Hz, average of 40 repetitions). Before
ischemia, five baseline SEPs were obtained, and the P1 to N1
amplitudes were averaged. SEP recovery is expressed as a percentage of
this baseline value. Subsequently, an 18-gauge blunt-tipped spinal
needle was inserted percutaneously in the
subarachnoid space at the base of the brain to measure
intracranial pressure and to infuse Elliott's B solution, a mock
cerebrospinal fluid.13 Prior to ischemia, the
rabbits were paralyzed with pancuronium bromide (0.1 mg/kg IV initially
and as needed). Cerebral ischemia was achieved by infusing the warmed (39°C) Elliott's B solution into the subarachnoid space so that intracranial pressure was equal to mean arterial pressure. Reperfusion was initiated by allowing the cerebrospinal fluid to drain until the intracranial pressure was less than 20 mm Hg. A cerebral perfusion pressure of at least 50 mm Hg was maintained during reperfusion by supporting the blood pressure as needed with fluid boluses and an epinephrine infusion.
Before the start of the experiment, rabbits were randomly selected to breathe either HBO or 100% oxygen at 1 atmosphere absolute after ischemia. All rabbits were subjected to 10 minutes of cerebral ischemia beginning at the time at which the SEP was undetectable. For the first 30 minutes after ischemia, animals in both groups breathed room air at ambient pressure. At the end of this period, the HBO rabbits were compressed to a depth of 2.8 atmospheres absolute where they breathed five cycles of oxygen and air, each for 20 and 5 minutes, respectively. This compression profile is a modification of US Navy Treatment Table 6.14 Decompression occurred in the last minute of the fifth air breathing period, after which the rabbits were maintained on 100% oxygen at ambient pressure for an additional 90 minutes. Control animals breathed 100% oxygen at 1 atmosphere absolute for an equivalent period of 215 minutes.
CBF was measured at the end of the 240-minute reperfusion period with [14C]iodoantipyrine autoradiography.15 Fifty µCi/kg of [14C]iodoantipyrine was administered over 1 minute, while aliquots of arterial blood were collected every 5 seconds for the determination of the concentration curve. After the isotope was infused, rabbits were immediately killed with T-61 euthanasia solution (Behring Diagnostics Inc), and brains were removed and frozen in isopentane at -60°C. Autoradiography was subsequently performed on 20-µm sections with Kodak SB-5 film. Optical density was measured using a photodensitometer with a 1-mm aperture in specific right and left brain regions by a technician who was blinded to treatment group. For each region, three measurements were made on three different sections, and the densities then were averaged. CBF was calculated using the concentration curve and the densitometry data. In an additional two animals, CBF was measured during the ischemic period.
Brain vascular permeability was assessed with Evans blue fluorescence according to the method of Saria and Lundberg.16 Thirty minutes before the end of the experiment, 3 mL/kg of a 2% solution of Evans blue in saline was given intravenously. Evans blue fluorescence was measured on the 20-µm sections used for autoradiography with a transmission fluorescence microscope (Carl Zeiss) equipped with a 100-W mercury lamp, BP 546, FT 580, and LP 590 filters, and a photometry computer program (Carl Zeiss). Relative intensity was determined at 540 nm after calibration with an area that had maximal intensity. Triplicate measurements were made and then averaged in each area of left and right cortical gray and left and right subcortical white matter.
Statistical analysis was performed using a PC-based software package (SOLO, version 3.0, BMDP Statistical Software). Group comparisons of physiological variables and SEP recovery were made with a repeated-measures ANOVA. CBF and Evans blue fluorescence data were analyzed with a three-factor (treatment group, right/left, brain region) ANOVA. Post hoc testing used the Student-Newman-Keuls test. All other data were analyzed with a Student's t test, except for the comparison of time from when the intracranial pressure equaled mean arterial pressure until the SEP was undetectable. The Mann-Whitney test was used for this analysis because the group variances were unequal. A value of P<.05 was considered significant. Data are expressed as mean±SEM.
| Results |
|---|
|
|
|---|
|
The time from when intracranial pressure equaled mean arterial pressure until the SEP was undetectable did not differ (P=.51) between the two groups. These times were 2.0±0.6 minutes for the HBO animals and 1.2±0.3 minutes for the control rabbits.
Evans blue fluorescence in gray and white matter was lower
(P=.017) in the HBO group compared with the control group
(Fig 1
). This indicates that animals
treated with HBO had a more intact blood-brain barrier than the
control rabbits, since intensity is directly proportional to vascular
permeability.
|
CBF was measured in five brain regions: cerebral cortex,
caudate/putamen, hippocampus, thalamus, and subcortical white matter.
The blood flow data are displayed in Fig 2
. There was no
difference (P=.54) between blood flow in the right and left
hemispheres, so these measurements were combined. Brain blood flow in
the HBO group (group mean, 40.9 mL/min per 100 g) was lower
(P=.003) than that of the control group (50.8 mL/min per 100
g) over all the regions, but there was no interaction between
experimental group and brain region (P=.75). No CBF was
detected during ischemia.
|
Fig 3
illustrates SEP recovery after ischemia.
Evoked potentials were acquired every 10 minutes during reperfusion.
Evoked potential recovery was not statistically different
(P=.13) between the two groups over the entire reperfusion
period. When examining SEP recovery from the point of initiation of
HBO, the groups also were similar (mean SEP, 32.7±3.2% in the HBO
group versus 25.6±3.2% in the control group; P=.13). Final
SEP recovery was higher in the HBO group (41.4±6.0%) compared with
controls (34.6±4.7%), but these values were not statistically
different (P=.53).
|
| Discussion |
|---|
|
|
|---|
HBO has previously been shown to increase17 or not alter18 the blood-brain barrier in uninjured animals, but no investigation had examined the direct effect of HBO on the blood-brain barrier after global cerebral ischemia. An increased permeability with HBO might have been expected in our study, since free radicals have been implicated in the breakdown of the blood-brain barrier after ischemia.19 20 In one investigation, polyethylene-conjugated superoxide dismutase and catalase administered to piglets before ischemia blunted the increase in vascular permeability observed after 2 hours of reperfusion.20 Since HBO has been shown to increase the amount of free radicals generated in tissues,11 21 an increased disruption of the blood-brain barrier might have been expected with HBO treatment. Nonetheless, we observed a reduction in vascular permeability after 4 hours of reperfusion. Our results suggest that if there were any detrimental effects of free radical generation with HBO, they were outweighed by the beneficial effects of HBO.
The actual mechanism by which HBO enhanced blood-brain barrier integrity is undefined. Takahashi et al8 speculated that HBO acts to restore ion pump function, whereas Contreras et al22 demonstrated that HBO improves postischemic cerebral metabolism. Ultimately, by increasing the amount of dissolved oxygen in the blood, HBO may act by improving tissue oxygen delivery. However, the independent effects of pressure cannot be excluded.
The effect of HBO treatment on the blood-brain barrier was modest, with a reduction of vascular permeability of 16% in gray matter and 20% in white matter. We assessed blood-brain barrier integrity early in reperfusion. Whether a more pronounced effect would be observed with a longer period of reperfusion will need to be investigated.
The precise mechanism of the increase in vascular permeability after cerebral ischemia and reperfusion is unknown, although roles for opening of the interendothelial tight junctions and pinocytotic transport have been advocated.23 We measured permeability at a time when the tight junctions are reportedly intact,20 making it unlikely that the reduction in Evans blue extravasation in the HBO group resulted from a reduced CBF.
We demonstrated a reduction in CBF 4 hours after ischemia in the HBO animals, but the implication of this finding is unclear. Interpretation of measurements of CBF is dependent on the time after ischemia at which the blood flow was measured. Immediately after global ischemia, there is an short, initial hyperemia followed by a period of hypoperfusion. The duration of this postischemic hypoperfusion crudely relates to the severity of the insult, but its importance in relation to recovery remains unknown.24 25 After about 3 hours, CBF generally increases, with a second hyperemia observed within 24 hours after ischemia.25 26 27 It has been suggested that the magnitude of this later increase inversely correlates with the severity of brain injury.25 28 This theory is supported by the observation that, in patients resuscitated after cardiac arrest, those with severe neurological damage had higher CBF within 24 hours after resuscitation compared with those who regained consciousness.28 Our results of a reduced CBF at 4 hours in the rabbits treated with HBO may be indicative of a less severely injured brain. This would be consistent with our finding of a more intact blood-brain barrier in these animals.
Alternatively, it could be argued that the reduction in CBF is harmful for brain recovery. Although we did not directly measure hemoglobin and oxygen saturation, it is likely that brain oxygen delivery in the HBO group at 4 hours after ischemia was lower than that in the control group, since the hematocrit and PaO2 in the groups were similar at the time of CBF measurement. Nonetheless, even though tissue oxygen delivery may have been reduced at 4 hours, we did not observe a decline in SEP recovery, and the CBF values obtained were well above those reported to be detrimental to brain recovery.29 These issues will require further investigation.
There are other factors that could account for the reduced CBF in the HBO rabbits. Generally, cerebral oxygen delivery is matched to oxygen consumption by changes in CBF,26 but several factors can alter this relationship. The cerebral perfusion pressure, PaCO2, and hematocrit can independently influence brain blood flow, but these variables were similar in the two groups and do not explain the lower CBF in the HBO group. Anesthetic agents can also affect CBF,30 but the animals in each group received the same agents and similar doses of drugs. Because elevations of PaO2 are associated with cerebral vasoconstriction,31 the reduced CBF could be due to high tissue levels of oxygen that persisted after HBO. However, in rats treated with HBO at 4 atmospheres absolute, the time after decompression for brain tissue to reach 95% of the baseline PO2 was 18.6 minutes.32 Since we measured blood flow 90 minutes after decompression, brain tissue PO2 was not likely to be elevated in the HBO group.
Other investigations have demonstrated that HBO decreases CBF in uninjured animals and humans; however, the reduction in flow was evident only during the exposure, and blood flow returned to the baseline level within the first 15 minutes after decompression.33 34 35 36 37 38 Furthermore, breathing 90% oxygen after compression did not alter the reestablishment of CBF to precompression levels.36 In our study, we noted a decrease in CBF after the HBO exposure. Only two previous investigations have examined the effect of HBO on CBF in the injured brain. Using animals subjected to a dural freeze lesion, Miller et al5 measured CBF during compression and found that regional blood flow was reduced by 19% during HBO. CBF was not evaluated after exposure. In another study, brain blood flow was measured before and about 2 hours after HBO treatment in five comatose, head-injured patients. HBO did not alter CBF, although there was a long delay in the initiation of treatment after injury, ranging from 5 to 20 days from the onset of coma.39
Few studies have examined the effect of HBO on brain recovery after global cerebral ischemia. Kapp et al2 subjected cats to 5 minutes of ischemia produced by occluding the ascending aorta and vena cava and found that animals treated with HBO for 2.5 hours had a significantly shortened electroencephalographic recovery time and a lower cerebrospinal fluid lactate level compared with controls ventilated with oxygen at ambient pressure. Takahashi et al8 showed that dogs treated with HBO after 15 minutes of global ischemia had improved survival and neurological outcome at 14 days when compared with untreated controls. These investigators also reported that HBO used in combination with nicardipine accelerated neurological recovery.40 However, Ruiz et al7 could not demonstrate an improved neurological outcome at 7 days after 12 minutes of ischemia and HBO therapy. An important difference between these investigations is that in their studies, Takahashi et al treated the animals with HBO on three separate occasions after ischemia, whereas Ruiz et al used a single treatment early in reperfusion. Furthermore, Ruiz et al used HBO in combination with hemodilution and magnesium infusion.
We used the amplitude of the SEP as an index of brain injury. Although
there has been some controversy regarding the correlation of SEP
improvement with neurological recovery, recent clinical studies
indicate that SEPs have prognostic utility.41 42 In
addition, this measurement has proved useful in the controlled
laboratory setting where SEP recovery has been shown to correlate with
the extent of cortical ischemia42 43 and brain
metabolism.45 46 Our inability to demonstrate
an improved electrophysiological recovery
with HBO may be related to a type II error, since the power to detect a
50% increase in SEP recovery at 4 hours was 0.70 (
=0.05). In a
previous study, we demonstrated that in rabbits treated with HBO
immediately after reperfusion SEP recovery at 75 minutes after
ischemia was twice that of control animals ventilated with room
air at ambient pressure.11
HBO reduced brain vascular permeability and CBF after global ischemia without altering SEP recovery. Our study suggests that HBO may be useful to promote integrity of the blood-brain barrier after global ischemia. This effect of HBO may prove the most valuable in the treatment of patients, since there are few therapies available that have been shown to reduce postischemic vascular permeability. However, it is uncertain whether the reduction in blood flow after HBO represents an improved outcome or would be detrimental to recovery. Because neurological recovery after global ischemia is generally unsatisfactory and treatment options are limited, HBO should be further investigated as a potential therapy. Additional animal investigations should be performed to determine the optimal compression regimen and to examine long-term neurological recovery with HBO treatment.
| Acknowledgments |
|---|
| Footnotes |
|---|
Received May 18, 1995; revision received September 11, 1995; accepted September 21, 1995.
| References |
|---|
|
|
|---|
2. Kapp JP, Phillips M, Markov A, Smith RR. Hyperbaric oxygen after circulatory arrest: modification of postischemic encephalopathy. Neurosurgery. 1982;11:496-499. [Medline] [Order article via Infotrieve]
3. Sukoff MH, Ragatz RE. Hyperbaric oxygenation for the treatment of acute cerebral edema. Neurosurgery. 1982;10:29-38. [Medline] [Order article via Infotrieve]
4. Sukoff MH, Hollin SA, Espinosa OE, Jacobson JH. The protective effect of hyperbaric oxygenation in experimental cerebral edema. J Neurosurg. 1968;29:236-241. [Medline] [Order article via Infotrieve]
5.
Miller JD, Ledingham IM, Jennett WB. Effects of
hyperbaric oxygen on intracranial pressure and cerebral blood flow in
experimental cerebral oedema. J Neurol
Neurosurg Psychiatry. 1970;33:745-755.
6.
Anderson DC, Bottini AG, Jagiella WM, Westphal B, Ford
S, Rockswold GL, Loewenson RB. A pilot study of hyperbaric
oxygen in the treatment of human stroke. Stroke. 1991;22:1137-1142.
7. Ruiz E, Brunette DD, Robinson EP, Tomlinson MJ, Lange J, Wieland MJ, Sherman R. Cerebral resuscitation after cardiac arrest using hetastarch hemodilution, hyperbaric oxygenation and magnesium ion. Resuscitation. 1986;14:213-233. [Medline] [Order article via Infotrieve]
8. Takahashi M, Iwatsuki N, Ono K, Tajima T, Akama M, Koga Y. Hyperbaric oxygen therapy accelerates neurologic recovery after 15-minute complete global cerebral ischemia in dogs. Crit Care Med. 1992;20:1588-1594. [Medline] [Order article via Infotrieve]
9. Rockswold GL, Ford SE, Anderson DC, Bergman TA, Sherman RE. Results of a prospective randomized trial for treatment of severely brain-injured patients with hyperbaric oxygen. J Neurosurg. 1992;76:929-934. [Medline] [Order article via Infotrieve]
10. Nemoto EM. Pathogenesis of cerebral ischemia-anoxia. Crit Care Med. 1978;6:203-214. [Medline] [Order article via Infotrieve]
11. Mink RB, Dutka AJ. Hyperbaric oxygen after global cerebral ischemia in rabbits does not promote brain lipid peroxidation. Crit Care Med. 1995;23:1398-1404. [Medline] [Order article via Infotrieve]
12. Marshall LF, Durity F, Lounsbury R, Graham DI, Welsh F, Langfitt TW. Experimental cerebral oligemia and ischemia produced by intracranial hypertension. J Neurosurg. 1975;43:308-317. [Medline] [Order article via Infotrieve]
13. Elliott KAC, Jasper HH. Physiologic salt solutions for brain surgery. J Neurosurg. 1949;6:140-152. [Medline] [Order article via Infotrieve]
14. US Navy Diving Manual, Vol 1: Air Diving. Revision 2. Washington, DC: Navsea publication 0994-LP-001-9010; June 1988.
15.
Sakurada O, Kennedy C, Hehle J, Brown JD, Carbin GL,
Sokoloff L. Measurement of local cerebral blood flow with
iodo[14C]antipyrine. Am J Physiol. 1978;234:H59-H66.
16. Saria A, Lundberg J. Evans blue fluorescence: quantitative and morphological evaluation of vascular permeability in animal tissues. J Neurosci Methods. 1983;8:41-49. [Medline] [Order article via Infotrieve]
17. Lanse SB, Lee JC, Jacobs EA, Brody H. Changes in the permeability of the blood-brain barrier under hyperbaric conditions. Aviat Space Environ Med. 1978;49:890-894. [Medline] [Order article via Infotrieve]
18. Grunenau SP, Folker MT, Rapoport SI. Lack of hyperbaric O2 effect on blood-brain barrier permeability in conscious rats. Aviat Space Environ Med. 1981;52:162-165. [Medline] [Order article via Infotrieve]
19. Tasdemiroglu E, Chistenberry PD, Ardell JL, Chronister RB, Taylor AE. Effect of superoxide dismutase on acute reperfusion injury of the rabbit brain. Acta Neurochir (Wien). 1993;120:180-186. [Medline] [Order article via Infotrieve]
20.
Armstead WM, Mirro R, Thelin OP, Shibata M, Zuckerman
SL, Shanklin DR, Busijia DW, Leffler CW. Polyethylene glycol
superoxide dismutase and catalase attenuate increased blood-brain
barrier permeability after ischemia in piglets.
Stroke. 1992;23:755-762.
21.
Yusa T, Beckman JS, Crapo JD, Freeman BA.
Hyperoxia increases H2O2 production by
brain in vivo. J Appl Physiol. 1987;63:353-358.
22. Contreras RL, Kadekaro M, Eisenberg HM. The effect of hyperbaric oxygen on glucose utilization in a freeze-traumatized rat brain. J Neurosurg. 1988;68:137-141. [Medline] [Order article via Infotrieve]
23. Kuroiwa T, Ting P, Martinex H, Klatzo I. The biphasic opening of the blood-brain barrier to proteins following temporary middle artery occlusion. Acta Neuropathol (Berl). 1985;68:122-129. [Medline] [Order article via Infotrieve]
24. Michenfelder JD, Milde JH. Postischemic canine cerebral blood flow appears to be determined by cerebral metabolic needs. J Cereb Blood Flow Metab. 1990;10:71-76. [Medline] [Order article via Infotrieve]
25. LaManna JC, Crumrine RC, Jackson DL. No correlation between cerebral blood flow and neurologic recovery after reversible total cerebral ischemia in the dog. Exp Neurol. 1988;101:234-247. [Medline] [Order article via Infotrieve]
26. Singh NC, Kochanek PM, Schiding JK, Melick JA, Nemoto EM. Uncoupled cerebral blood flow and metabolism after severe global ischemia in rats. J Cereb Blood Flow Metab. 1992;12:802-808. [Medline] [Order article via Infotrieve]
27. Pulsinelli WA, Levy DE, Duffy TE. Regional cerebral blood flow and glucose metabolism following transient forebrain ischemia. Ann Neurol. 1982;11:499-509. [Medline] [Order article via Infotrieve]
28.
Cohan SL, Mun SK, Petite J, Correia J, Da Silva AT,
Waldhorn RE. Cerebral blood flow in humans following
resuscitation from cardiac arrest. Stroke. 1989;20:761-765.
29. Symon L. The relationship between CBF, evoked potentials and the clinical features in cerebral ischemia. Acta Neurol Scand. 1980;78:175-190.
30.
Helfaer MA, Kirsch JR, Traystman RJ. Anesthetic
modulation of cerebral hemodynamic and evoked responses
to transient middle cerebral artery occlusion in cats.
Stroke. 1990;21:795-800.
31.
Regli F, Yamaguchi T, Waltz AG. Effects of
inhalation of oxygen on blood flow and microvasculature of
ischemic and nonischemic cerebral cortex.
Stroke. 1970;1:314-319.
32.
Jamieson K, van den Brenk HAS. Measurement of
oxygen tensions in cerebral tissues of rats exposed to high pressures
of oxygen. J Appl Physiol. 1963;18:869-876.
33.
Hayakawa T, Kuroda R, Yamada R, Mogami H.
Response of cerebrospinal fluid pressure to hyperbaric
oxygenation. J Neurol Neurosurg
Psychiatry. 1971;34:580-586.
34. Bergö GW, Tyssebotn I. Cerebral blood flow distribution during exposure to 5 bar oxygen in awake rats. Undersea Biomed Res. 1992;19:339-354. [Medline] [Order article via Infotrieve]
35.
Kanai N, Hayakawa T, Mogami H. Blood flow
changes in carotid and vertebral arteries by hyperbaric
oxygenation. Neurology. 1973;23:159-163.
36. Tindall GT, Wilkins RH, Odom GL. Effect of hyperbaric oxygenation on cerebral blood flow. Surg Forum. 1965;16:414-416. [Medline] [Order article via Infotrieve]
37. Jacobson I, Harper AM, McDowall DG. The effects of oxygen under pressure on cerebral blood-flow and cerebral venous oxygen tension. Lancet. 1963;2:549. [Medline] [Order article via Infotrieve]
38.
Lambertsen CJ, Kough RH, Cooper DY, Emmel GL, Loeschcke
JJ, Schmidt CF. Oxygen toxicity: effects in man of oxygen
inhalation at 1 and 3.5 atmospheres upon blood gas transport, cerebral
circulation and cerebral metabolism. J
Appl Physiol. 1953;5:471-486.
39. Artru F, Philippon B, Gau F, Berger M, Deleuze R. Cerebral blood flow, cerebral metabolism and cerebrospinal fluid biochemistry in brain-injured patients after exposure to hyperbaric oxygen. Eur Neurol. 1976;14:351-364. [Medline] [Order article via Infotrieve]
40. Iwatsuki N, Takahashi M, Ono K, Tajima T. Hyperbaric oxygen combined with nicardipine administration accelerates neurologic recovery after cerebral ischemia in a canine model. Crit Care Med. 1994;22:858-863. [Medline] [Order article via Infotrieve]
41. Beca J, Cox PN, Taylor MJ, Bohn D, Butt W, Logan WJ, Rutka JT, Barker G. Somatosensory evoked potentials for prediction of outcome in acute severe brain injury. J Pediatr. 1995;126:44-49. [Medline] [Order article via Infotrieve]
42.
Gott PS, Karnaze DS, Fisher M. Assessment of
median nerve somatosensory evoked potentials in cerebral
ischemia. Stroke. 1990;21:1167-1171.
43.
Ropper AH. Evoked potentials in cerebral
ischemia. Stroke. 1986;17:3-5.
44. Lopes Da Silva FH, Van Dieren A, Jonkman J, Tulleken CAF. Chronic brain ischemia in the monkey assessed by somatosensory evoked potentials and local cerebral blood flow measurements. Behav Brain Res. 1985;15:147-157. [Medline] [Order article via Infotrieve]
45.
McPherson RW, Zeger S, Traystman RJ.
Relationship of somatosensory evoked potentials and cerebral oxygen
consumption during hypoxic hypoxia in dogs.
Stroke. 1986;17:30-36.
46.
Hurn PD, Koehler RC, Norris SE, Blizzard KK, Traystman
RJ. Dependence of cerebral energy phosphate and evoked potential
recovery on end-ischemic pH. Am J
Physiol. 1991;260:H532-H541.
This article has been cited by other articles:
![]() |
Z. Qin, M. Karabiyikoglu, Y. Hua, R. Silbergleit, Y. He, R. F. Keep, and G. Xi Hyperbaric Oxygen-Induced Attenuation of Hemorrhagic Transformation After Experimental Focal Transient Cerebral Ischemia Stroke, April 1, 2007; 38(4): 1362 - 1367. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Calvert, J. Cahill, M. Yamaguchi-Okada, and J. H. Zhang Oxygen treatment after experimental hypoxia-ischemia in neonatal rats alters the expression of HIF-1{alpha} and its downstream target genes J Appl Physiol, September 1, 2006; 101(3): 853 - 865. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Hankey, M. H. Bennett, J. Wasiak, C. French, P. Kranke, and A. Schnabel Hyperbaric Oxygen Therapy for Acute Ischemic Stroke Stroke, July 1, 2006; 37(7): 1953 - 1954. [Full Text] [PDF] |
||||
![]() |
R. Veltkamp, D. A. Siebing, L. Sun, S. Heiland, K. Bieber, H. H. Marti, S. Nagel, S. Schwab, and M. Schwaninger Hyperbaric Oxygen Reduces Blood-Brain Barrier Damage and Edema After Transient Focal Cerebral Ischemia Stroke, August 1, 2005; 36(8): 1679 - 1683. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Rusyniak, M. A. Kirk, J. D. May, L. W. Kao, E. J. Brizendine, J. L. Welch, W. H. Cordell, and R. J. Alonso Hyperbaric Oxygen Therapy in Acute Ischemic Stroke: Results of the Hyperbaric Oxygen in Acute Ischemic Stroke Trial Pilot Study Stroke, February 1, 2003; 34(2): 571 - 574. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Badr, W. Yin, G. Mychaskiw, and J. H. Zhang Dual effect of HBO on cerebral infarction in MCAO rats Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2001; 280(3): R766 - R770. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Muth and E. S. Shank Gas Embolism N. Engl. J. Med., February 17, 2000; 342(7): 476 - 482. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |